Fong Chi Cheng

Summary

Affiliation: MDS Pharma Services
Country: France

Publications

  1. ncbi Effects of chlorella on activities of protein tyrosine phosphatases, matrix metalloproteinases, caspases, cytokine release, B and T cell proliferations, and phorbol ester receptor binding
    Fong Chi Cheng
    MDS Pharma Services Taiwan Ltd, 158 Li Teh Road, Taipei 112, Taiwan, Republic of China
    J Med Food 7:146-52. 2004
  2. ncbi The neuroprotective effects of BNG-1: a new formulation of traditional Chinese medicines for stroke
    Fong Chi Cheng
    MDS Pharma Services Taiwan, Ltd, Taipei 112, Taiwan
    Am J Chin Med 33:61-71. 2005
  3. ncbi Receptor binding activities of Chlorella on cysteinyl leukotriene CysLT, glutamate AMPA, ion channels, purinergic P 2Y, tachykinin NK2 receptors and adenosine transporter
    Fong Chi Cheng
    MDS Pharma Services Taiwan Ltd, 158 Li Teh Road, Peitou, Taipei, 112, Taiwan, ROC
    Phytother Res 24:43-8. 2010
  4. ncbi Chlorella powder inhibits the activities of peptidase cathepsin S, PLA2, cyclooxygenase-2, thromboxane synthase, tyrosine phosphatases, tumor necrosis factor-alpha converting enzyme, calpain and kinases
    Fong Chi Cheng
    MDS Pharma Services Taiwan, Ltd, Taipei, Taiwan, Republic of China
    Int J Food Sci Nutr 60:89-98. 2009
  5. ncbi Validation of a [3H]astemizole binding assay in HEK293 cells expressing HERG K+ channels
    Peter J S Chiu
    MDS Pharma Services, 22011 30th Drive SE, Bothell, WA 98021 4444, USA
    J Pharmacol Sci 95:311-9. 2004
  6. ncbi A potential role of YC-1 on the inhibition of cytokine release in peripheral blood mononuclear leukocytes and endotoxemic mouse models
    Shiow-Lin Pan
    Pharmacological Institutes, College of Medicine, National Taiwan University, Taipei
    Thromb Haemost 93:940-8. 2005
  7. ncbi YC-1 [3-(5'-hydroxymethyl-2'-furyl)-1-benzyl indazole] inhibits endothelial cell functions induced by angiogenic factors in vitro and angiogenesis in vivo models
    Shiow-Lin Pan
    Pharmacological Institute, College of Medicine, National Taiwan University, 1 Jen-Ai Road, Section 1, Taipei, Taiwan
    J Pharmacol Exp Ther 314:35-42. 2005
  8. ncbi Design and synthesis of potent cystine-free cyclic hexapeptide agonists at the human urotensin receptor
    Shane Foister
    Department of Chemistry, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    Org Lett 8:1799-802. 2006
  9. ncbi An in vivo analysis of the herbal compound essiac
    Blair J N Leonard
    Faculty of Medicine, University of Toronto, Toronto, ON, Canada
    Anticancer Res 26:3057-63. 2006
  10. ncbi Identification of a novel competitive inhibitor of p38alpha MAPK by a human PBMC screen
    Yu Chih Liu
    Graduate Institute of Biochemistry and Molecular Biology, College of Medicine, National Taiwan University, Taipei 100, Taiwan
    Biochem Biophys Res Commun 352:656-61. 2007

Collaborators

  • Hideo Takekoshi
  • Jin Jye Feng
  • Toru Mizoguchi
  • Peter J S Chiu
  • W J Crumb
  • Richard N Mitchell
  • Kuo Long Lou
  • Amos B Smith
  • Shiow-Lin Pan
  • Ralph Hirschmann
  • Atsui Lin
  • Yu Chih Liu
  • Blair J N Leonard
  • Shane Foister
  • Jau-Hsiang Chang
  • Jih-Hwa Guh
  • Ya-Ling Chang
  • Santhosh Neelamkavil
  • Che-Ming Teng
  • Laurie Taylor
  • Chieh-Yu Peng
  • Kuo-Hsin Chen
  • Fang-Yu Lee
  • Sheng-Chu Kuo
  • Chia-Chen Ko
  • Chia Chen Ko
  • Yu-Chih Liu
  • Po-Tsang Huang
  • Lu Ping Chow
  • Lu-Ping Chow
  • Po Tsang Huang
  • Deborah A Kennedy
  • Laurie L Taylor
  • Dugald Seely
  • Wen-Long Chen
  • Keng-Kuang Chang
  • Edward Mills
  • Osamu Kikuchi
  • Byron Arison
  • Edward R Thornton
  • Adam K Charnley
  • Eugen F Mesaros
  • Chi-Lien Chu
  • Andrew Benowitz
  • Elizabeth Birzin
  • Shih-Wei Wang
  • Wenyong Wang

Detail Information

Publications12

  1. ncbi Effects of chlorella on activities of protein tyrosine phosphatases, matrix metalloproteinases, caspases, cytokine release, B and T cell proliferations, and phorbol ester receptor binding
    Fong Chi Cheng
    MDS Pharma Services Taiwan Ltd, 158 Li Teh Road, Taipei 112, Taiwan, Republic of China
    J Med Food 7:146-52. 2004
    ..These results reveal potential pharmacological activities that, if confirmed by in vivo studies, might be exploited for the prevention or treatment of several serious pathologies, including inflammatory disease and cancer...
  2. ncbi The neuroprotective effects of BNG-1: a new formulation of traditional Chinese medicines for stroke
    Fong Chi Cheng
    MDS Pharma Services Taiwan, Ltd, Taipei 112, Taiwan
    Am J Chin Med 33:61-71. 2005
    ..Moreover, the fundamental cellular mechanism underlying its therapeutic effects may result from phosphodiesterase inhibition...
  3. ncbi Receptor binding activities of Chlorella on cysteinyl leukotriene CysLT, glutamate AMPA, ion channels, purinergic P 2Y, tachykinin NK2 receptors and adenosine transporter
    Fong Chi Cheng
    MDS Pharma Services Taiwan Ltd, 158 Li Teh Road, Peitou, Taipei, 112, Taiwan, ROC
    Phytother Res 24:43-8. 2010
    ..These results reveal important potential biochemical activities that might be exploited for the prevention or treatment of several pathologies. From these results, the possible therapeutic usage of the product is discussed...
  4. ncbi Chlorella powder inhibits the activities of peptidase cathepsin S, PLA2, cyclooxygenase-2, thromboxane synthase, tyrosine phosphatases, tumor necrosis factor-alpha converting enzyme, calpain and kinases
    Fong Chi Cheng
    MDS Pharma Services Taiwan, Ltd, Taipei, Taiwan, Republic of China
    Int J Food Sci Nutr 60:89-98. 2009
    ....
  5. ncbi Validation of a [3H]astemizole binding assay in HEK293 cells expressing HERG K+ channels
    Peter J S Chiu
    MDS Pharma Services, 22011 30th Drive SE, Bothell, WA 98021 4444, USA
    J Pharmacol Sci 95:311-9. 2004
    ..91, P<0.05). In conclusion, the [(3)H]astemizole binding assay is rapid and capable of detecting HERG inhibitors...
  6. ncbi A potential role of YC-1 on the inhibition of cytokine release in peripheral blood mononuclear leukocytes and endotoxemic mouse models
    Shiow-Lin Pan
    Pharmacological Institutes, College of Medicine, National Taiwan University, Taipei
    Thromb Haemost 93:940-8. 2005
    ..It is suggested that YC-1 may be a potential agent for the therapeutic treatment of sepsis...
  7. ncbi YC-1 [3-(5'-hydroxymethyl-2'-furyl)-1-benzyl indazole] inhibits endothelial cell functions induced by angiogenic factors in vitro and angiogenesis in vivo models
    Shiow-Lin Pan
    Pharmacological Institute, College of Medicine, National Taiwan University, 1 Jen-Ai Road, Section 1, Taipei, Taiwan
    J Pharmacol Exp Ther 314:35-42. 2005
    ..YC-1 may be useful for treating angiogenesis-dependent human diseases such as cancer...
  8. ncbi Design and synthesis of potent cystine-free cyclic hexapeptide agonists at the human urotensin receptor
    Shane Foister
    Department of Chemistry, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    Org Lett 8:1799-802. 2006
    ..Further development led to a hexapeptide agonist with nanomolar affinity (2.8 nM)...
  9. ncbi An in vivo analysis of the herbal compound essiac
    Blair J N Leonard
    Faculty of Medicine, University of Toronto, Toronto, ON, Canada
    Anticancer Res 26:3057-63. 2006
    ..CONCLUSION: Essiac, administered in established in vivo experimental models, did not significantly demonstrate its purported physiological modifying effects...
  10. ncbi Identification of a novel competitive inhibitor of p38alpha MAPK by a human PBMC screen
    Yu Chih Liu
    Graduate Institute of Biochemistry and Molecular Biology, College of Medicine, National Taiwan University, Taipei 100, Taiwan
    Biochem Biophys Res Commun 352:656-61. 2007
    ..13 and 0.55 microM, respectively. Further characterization of enzyme kinetics showed the binding mode of MT4 was competitive with the ATP substrate-binding site of p38alpha MAPK...
  11. ncbi Design, synthesis, and binding affinities of pyrrolinone-based somatostatin mimetics
    Amos B Smith
    Department of Chemistry, University of Pennsylvania, Philadelphia, PA 19104, USA
    Org Lett 7:399-402. 2005
    ..Binding affinities at two somatostatin receptor subtypes (hsst 4 and 5) reveal micromolar activity, demonstrating that the d,l-mixed pyrrolinone scaffold can be employed to generate functional mimetics of peptide beta-turns...
  12. ncbi Replacement of Phe6, Phe7, and Phe11 of D-Trp8-somatostatin-14 with L-pyrazinylalanine. Predicted and observed effects on binding affinities at hSST2 and hSST4. An unexpected effect of the chirality of Trp8 on NMR spectra in methanol
    Santhosh Neelamkavil
    Department of Chemistry, University of Pennsylvania, Philadelphia, 19104, USA
    J Med Chem 48:4025-30. 2005
    ..Finally, the chirality of Trp(8) was unexpectedly found to have a striking effect on NMR spectra in methanol, especially at lower temperatures...